Multiplus Holdings is a financial services firm that generates income through investment activities, professional consultancy, and trading in securities and mutual funds.
The company lacks a sustainable competitive advantage, as evidenced by its reliance on passive investment income and a low average ROCE of 6.1%. There is no evidence of proprietary technology, brand power, or cost advantages that would protect its margins from market volatility.
Management primarily allocates capital to mutual funds and fixed maturity plans rather than reinvesting in business growth. While they pay occasional small dividends, the lack of a clear strategy for operating cash flow suggests a passive holding company approach rather than active value creation.
Five years later, the capital is halved because the company remained a stagnant pool of idle assets rather than a productive enterprise. Management's refusal to reinvest in operations led to a slow decay of the core business, while the portfolio of mutual funds and fixed maturity plans suffered from poor timing and market volatility. The lack of institutional oversight and minimal compliance standards eventually resulted in a regulatory crackdown or a quiet siphoning of value by the controlling promoters, leaving minority shareholders with a shell of a company that the market correctly priced at a massive discount to its book value.
RichFakir rates Multiplus Holdings Ltd's business quality as poor — 35/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Multiplus Holdings Ltd is trading about 65% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Multiplus Holdings Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Multiplus Holdings Ltd's fair value is about ₹93 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →